Elutia Inc. (NASDAQ:ELUT) today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its next-generation drug-eluting biomatrix product, CanGarooRM®. Tailored
Companies Reporting Before The Bell
• Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter.
• Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
- Company Now Focused on Proprietary Drug-Eluting Biomatrix Platform -SILVER SPRING, Md., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (NASDAQ:ELUT) ("Elutia"), a company pioneering drug-eluting biomatrix products,